Literature DB >> 32524630

Rash as a presenting complaint in a child with COVID-19.

Anna Klimach1, Jordan Evans1, Jennifer Stevens1, Nikola Creasey1.   

Abstract

Cutaneous manifestations are becoming increasingly well-documented in adults with COVID-19. There is now also a growing body of literature regarding skin involvement in children, with reports of papulovesicular, petechial and widespread macular and papular lesions, and chilblains (pernio). We describe the case of a 13-year-old boy with confirmed COVID-19 in the United Kingdom who presented with skin findings localized to the plantar aspects of the feet, axillae, and lower limbs. The morphology was predominantly maculopapular but also included petechiae and annular lesions.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; child; pediatric; rash

Mesh:

Year:  2020        PMID: 32524630      PMCID: PMC7307022          DOI: 10.1111/pde.14257

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.997


INTRODUCTION

Diagnosis of COVID‐19 in children is currently uncommon compared to adults. Children who are symptomatic most commonly display cough, fever, pharyngeal erythema, and gastrointestinal symptoms. In children, cutaneous manifestations include widespread erythematous macular and papular lesions, a skin rash in the context of a multisystem inflammatory state or similar clinical presentation to Kawasaki's disease, and papulovesicular eruptions. , We report a case of confirmed COVID‐19 in a child who presented with skin findings localized to the axillae, lower limbs, and plantar aspects of the feet.

CASE REPORT

A 13‐year‐old boy presented in April 2020 with the chief complaint of pain in the soles of his feet. He also had a 24‐hour history of fever, myalgia, and headache. He denied any respiratory symptoms. He had taken acetaminophen infrequently. He was previously fit and well with no comorbidities. His stepfather reported a flu‐like illness and his mother a mild cough. On examination, he was systemically well with normal vital signs. There was an erythematous papular eruption in the axillae with axillary and cervical lymphadenopathy, all nodes measuring <1 cm. On the plantar surface of his feet were multiple tender, erythematous papules each measuring approximately 1 cm (Figure 1). There were no vesicles or pustules. Erythematous macules with associated scattered petechiae, located in close proximity to the macules, were also present on the child's distal lower extremities (Figure 2).
Figure 1

Feet—Multiple erythematous, tender papules, each measuring approximately 1 cm, were present on the plantar aspects of the feet

Figure 2

Lower limbs—A macular rash with associated scattered petechiae was present on the lower limbs at presentation. An annular lesion developed following discharge

Feet—Multiple erythematous, tender papules, each measuring approximately 1 cm, were present on the plantar aspects of the feet Lower limbs—A macular rash with associated scattered petechiae was present on the lower limbs at presentation. An annular lesion developed following discharge Coagulation profile and full blood count were within normal range. C‐reactive protein was 10 mg/L. Polymerase chain reaction (PCR) for SARS‐CoV‐2 was positive. PCR was negative for all seasonal respiratory viruses (influenza A, influenza B, parainfluenza, respiratory syncytial virus, rhinovirus, enterovirus, human metapneumovirus, adenovirus, Mycoplasma pneumoniae, enterovirus, and seasonal coronavirus). The clinical photographs provided were taken by the family 2 days after presentation, at which point annular lesions were evident on the distal lower extremities. He continued to have intermittent mild flu‐like symptoms for 5 days but did not develop any cough or dyspnea. The skin changes fully resolved within 10‐14 days.

DISCUSSION

Currently, the most commonly reported symptoms of COVID‐19 in the pediatric population are cough and fever. The adult literature describes erythematous rashes, chilblains, urticaria, vesicular lesions, petechiae, purpura, and papules. There is also reference to localization to the axillae and soles of the feet. A common theme in the adult data is the hypothesis that the skin findings are secondary to a drug reaction in view of the use of experimental treatments such as hydroxychloroquine and lopinavir. Our patient only had exposure to infrequent acetaminophen, supporting the likelihood that the cutaneous manifestations are a direct result of the SARS‐CoV‐2 virus and the host immune response. At this current time, pediatric health care providers should consider the diagnosis of COVID‐19 in children presenting with not only widespread papulovesicular and macular and papular lesions but also localized lesions with varied morphology including plantar papules, petechiae, and annular lesions.
  5 in total

1.  COVID-19 and Kawasaki Disease: Novel Virus and Novel Case.

Authors:  Veena G Jones; Marcos Mills; Dominique Suarez; Catherine A Hogan; Debra Yeh; J Bradley Segal; Elizabeth L Nguyen; Gabrielle R Barsh; Shiraz Maskatia; Roshni Mathew
Journal:  Hosp Pediatr       Date:  2020-04-07

2.  Cutaneous manifestations in COVID-19: a first perspective.

Authors:  S Recalcati
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-05       Impact factor: 6.166

3.  Varicella-like exanthem associated with COVID-19 in an 8-year-old girl: A diagnostic clue?

Authors:  Giovanni Genovese; Cristiana Colonna; Angelo V Marzano
Journal:  Pediatr Dermatol       Date:  2020-05-19       Impact factor: 1.997

4.  Reply to "COVID-19 can present with a rash and be mistaken for dengue": Petechial rash in a patient with COVID-19 infection.

Authors:  Juan Jimenez-Cauhe; Daniel Ortega-Quijano; Marta Prieto-Barrios; Oscar M Moreno-Arrones; Diego Fernandez-Nieto
Journal:  J Am Acad Dermatol       Date:  2020-04-10       Impact factor: 11.527

5.  SARS-CoV-2 Infection in Children.

Authors:  Xiaoxia Lu; Liqiong Zhang; Hui Du; Jingjing Zhang; Yuan Y Li; Jingyu Qu; Wenxin Zhang; Youjie Wang; Shuangshuang Bao; Ying Li; Chuansha Wu; Hongxiu Liu; Di Liu; Jianbo Shao; Xuehua Peng; Yonghong Yang; Zhisheng Liu; Yun Xiang; Furong Zhang; Rona M Silva; Kent E Pinkerton; Kunling Shen; Han Xiao; Shunqing Xu; Gary W K Wong
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

  5 in total
  12 in total

Review 1.  Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride.

Authors:  Ignacio J Ansotegui; Jonathan A Bernstein; Giorgio W Canonica; Sandra N Gonzalez-Diaz; Bryan L Martin; Mario Morais-Almeida; Margarita Murrieta-Aguttes; Mario Sanchez Borges
Journal:  Allergy Asthma Clin Immunol       Date:  2022-05-13       Impact factor: 3.373

2.  COVID-19 cutaneous manifestations in children and adolescents: a systematic review.

Authors:  Ricardo Pasquini Neto; Felipe Antonio Torres Mazzo; Fernanda de Almeida Vieira; Gustavo de Souza Bueno; João Vitor Correa Previdi; Lara Rozetti da Silva; Nasthia Kreuz Baziulis da Silva; Joseph Lucius Jorizzo; Felipe Bochnia Cerci
Journal:  Rev Paul Pediatr       Date:  2022-06-10

Review 3.  Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment.

Authors:  Jessica Fennell; Karen Onel
Journal:  Front Pediatr       Date:  2022-06-23       Impact factor: 3.569

Review 4.  Maculopapular skin eruptions associated with Covid-19: A systematic review.

Authors:  Saad Shams; Sawai Singh Rathore; Priyanka Anvekar; Manush Sondhi; Neeraj Kancherla; Sohaib Tousif; Gianpier Alonzo Rojas; Noman Khurshid Ahmed; Mehwish Munawwar; Muhammad Noman
Journal:  Dermatol Ther       Date:  2021-02-02       Impact factor: 3.858

Review 5.  Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review.

Authors:  Claudio Conforti; Caterina Dianzani; Marina Agozzino; Roberta Giuffrida; Giovanni Francesco Marangi; Nicola di Meo; Silviu-Horia Morariu; Paolo Persichetti; Francesco Segreto; Iris Zalaudek; Nicoleta Neagu
Journal:  Biology (Basel)       Date:  2020-12-05

Review 6.  Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.

Authors:  Désirée Larenas-Linnemann; Jorge Luna-Pech; Elsy M Navarrete-Rodríguez; Noel Rodríguez-Pérez; Alfredo Arias-Cruz; María Virginia Blandón-Vijil; Blanca E Del Rio-Navarro; Alan Estrada-Cardona; Ernesto Onuma-Takane; Cesar Fireth Pozo-Beltrán; Adriana María Valencia-Herrera; Francisco Ignacio Ortiz-Aldana; Mirna Eréndira Toledo-Bahena
Journal:  Curr Allergy Asthma Rep       Date:  2021-02-25       Impact factor: 4.806

Review 7.  Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses.

Authors:  Surabhi Sharma; Edward Raby; Sujith Prasad Kumarasinghe
Journal:  Australas J Dermatol       Date:  2021-02-17       Impact factor: 2.481

8.  Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection.

Authors:  Ritu N Swali; Erica B Lee; Jennifer L Adams
Journal:  Pediatr Dermatol       Date:  2021-02-28       Impact factor: 1.997

Review 9.  Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate.

Authors:  Michael Joseph Lavery; Charles Alexis Bouvier; Ben Thompson
Journal:  Clin Dermatol       Date:  2020-11-01       Impact factor: 3.541

Review 10.  Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article.

Authors:  Maryam Khalili; Behzad Iranmanesh; Saman Mohammadi; Mahin Aflatoonian
Journal:  Dermatol Ther       Date:  2020-12-08       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.